Galmed Pharmaceuticals
GLMD
GLMD
42 hedge funds and large institutions have $52.2M invested in Galmed Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less call options, than puts
Call options by funds: $87K | Put options by funds: $126K
50% less capital invested
Capital invested by funds: $103M → $52.2M (-$51.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
42
Holding in Top 10
1
Calls
$87K
Puts
$126K
Top Buyers
| 1 | +$1.31M | |
| 2 | +$818K | |
| 3 | +$799K | |
| 4 |
II
Ibex Investors
Denver,
Colorado
|
+$561K |
| 5 |
SIM
Spark Investment Management
New York
|
+$507K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.56M | |
| 3 | -$782K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$741K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$599K |